Canada Life
LJPC

Canada Life’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Canada Life’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,654
Closed -$17K – 2848
2019
Q1 		$17K Hold
2,654
– – ﹤0.01% 2378
2018
Q4 		$24K Hold
2,654
– – ﹤0.01% 2522
2018
Q3 		$53K Hold
2,654
– – ﹤0.01% 2387
2018
Q2 		$77K Hold
2,654
– – ﹤0.01% 2285
2018
Q1 		$79K Hold
2,654
– – ﹤0.01% 2243
2017
Q4 		$85K Hold
2,654
– – ﹤0.01% 2215
2017
Q3 		$91K Hold
2,654
– – ﹤0.01% 2183
2017
Q2 		$79K Hold
2,654
– – ﹤0.01% 2182
2017
Q1 		$79K Hold
2,654
– – ﹤0.01% 2183
2016
Q4 		$47K Hold
2,654
– – ﹤0.01% 2340
2016
Q3 		$63K Hold
2,654
– – ﹤0.01% 2285
2016
Q2 		$42K Hold
2,654
– – ﹤0.01% 2352
2016
Q1 		$55K Hold
2,654
– – ﹤0.01% 2092
2015
Q4 		$72K Buy
+2,654
New +$72.4K ﹤0.01% 1976

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Canada Life's LJPC Position: Q2 2019 in Review

Canada Life sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2019, closing a stake of 2,654 shares — an estimated $17K sold.

Canada Life first reported a position in LJPC in Q4 2015 and held it in 14 quarters. The position peaked at $91K in Q3 2017. 80 funds tracked by Wall St. Rank hold LJPC as of Q2 2019.

  • Canada Life reported no remaining La Jolla Pharmaceutical Company position as of Q2 2019 after selling out during the quarter.
  • Canada Life sold 2,654 La Jolla Pharmaceutical Company shares in Q2 2019, an estimated $17K.
  • Canada Life first reported a position in La Jolla Pharmaceutical Company in Q4 2015 and held it in 14 quarters.
  • Canada Life's La Jolla Pharmaceutical Company position peaked at $91K in Q3 2017.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2019.

Based on Canada Life's 13F filing for Q2 2019, filed 31 Jul 2019.